MR

Mitchell E. Reff

IP Idec Pharmaceuticals: 11 patents #3 of 30Top 10%
BI Biogen Idec: 6 patents #6 of 60Top 10%
BM Biogen Idec Ma: 6 patents #33 of 270Top 15%
SE Seikagaku: 1 patents #133 of 253Top 55%
Overall (All Time): #175,014 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8603473 Modified binding molecules comprising connecting peptides Scott Glaser, Tzung-Horng Yang, Xiufeng Wu, Paul Chinn 2013-12-10
7744877 Expression and use of anti-CD20 Antibodies Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter 2010-06-29
7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics William Kloetzer, Takehiko Nakamura 2010-04-13
7452534 Recombinant anti-CD4 antibodies for human therapy Nabil Hanna, Roland A. Newman 2008-11-18
7438906 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics William Kloetzer, Takehiko Nakamura 2008-10-21
7422739 Anti-CD20 antibodies Darrell R. Anderson, Nabil Hanna, Roland A. Newman, William H. Rastetter 2008-09-09
7381560 Expression and use of anti-CD20 antibodies Darrell R. Anderson, Nabil Hanna, Roland A. Newman, William H. Rastetter 2008-06-03
7338658 Recombinant anti-CD4 antibodies for human therapy Nabil Hanna, Roland A. Newman 2008-03-04
7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics William Kloetzer, Takehiko Nakamura 2008-02-19
7223392 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics William Kloetzer, Takehiko Nakamura 2007-05-29
7033589 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics William Kloetzer, Takehiko Nakamura 2006-04-25
6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics William Kloetzer, Takehiko Nakamura 2005-05-17
6682734 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter 2004-01-27
6399061 Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma Darrell R. Anderson, Nabil Hanna, Roland A. Newman, William H. Rastetter 2002-06-04
6159730 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same 2000-12-12
6136310 Recombinant anti-CD4 antibodies for human therapy Nabil Hanna, Roland A. Newman 2000-10-24
6017733 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same 2000-01-25
6011138 Gamma-1 anti-human CD23 monoclonal antibodies William Kloetzer, Takehiko Nakamura 2000-01-04
5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter 1998-12-01
5830698 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same Richard S. Barnett, Karen McLachlan 1998-11-03
5776456 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter 1998-07-07
5736137 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter 1998-04-07
5733779 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same 1998-03-31
5648267 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same 1997-07-15